Continuing from here…
Irrespective of Arati Ramesh’s words and actions, I find every retraction worth celebrating because how hard-won retractions in general have been, in India and abroad. I don’t know how often papers coauthored by Indian scientists are retracted and how high or low that rate is compared to the international average. But I know that the quality of scientific work emerging from India is grossly disproportionate (in the negative sense) to the size of the country’s scientific workforce, which is to say most of the papers published from India, irrespective of the journal, contain low-quality science (if they contain science at all). It’s not for nothing that Retraction Watch has a category called ‘India retractions’, with 196 posts.
Second, it’s only recently that the global scientific community’s attitude towards retractions started changing, and even now most of it is localised to the US and Europe. And even there, there is a distinction: between retractions for honest mistakes and those for dishonest mistakes. Our attitudes towards retractions for honest mistakes have been changing. Retractions for dishonest conduct, or misconduct, have in fact been harder to secure, and continue to be.
The work of science integrity consultant Elisabeth Bik allows us a quick take: the rate at which sleuths are spotting research fraud is far higher than the rate at which journals are retracting the corresponding papers. Bik herself has often said on Twitter and in interviews how most journals editors simply don’t respond to complaints, or quash them with weak excuses and zero accountability. Between 2015 and 2019, a group of researchers identified papers that had been published in violation of the CONSORT guidelines in journals that endorsed the same guidelines, and wrote to those editors. From The Wire Science‘s report:
… of the 58 letters sent to the editors, 32 were rejected for different reasons. The BMJ and Annals published all of those addressed to them. The Lancet accepted 80% of them. The NEJM and JAMA turned down every single letter.
According to JAMA, the letters did not include all the details it required to challenge the reports. When the researchers pointed out that JAMA’s word limit for the letter precluded that, they never heard back from the journal.
On the other hand, NEJM stated that the authors of reports it published were not required to abide by the CONSORT guidelines. However, NEJM itself endorses CONSORT.
The point is that bad science is hard enough to spot, and getting stakeholders to act on them is even harder. It shouldn’t have to be, but it is. In this context, every retraction is a commendable thing – no matter how obviously warranted it is. It’s also commendable when a paper ‘destined’ for retraction is retracted sooner (than the corresponding average) because we already have some evidence that “papers that scientists couldn’t replicate are cited more”. Even if a paper in the scientific literature dies, other scientists don’t seem to be able to immediately recognise that it is dead and cite it in their own work as evidence of this or that thesis. These are called zombie citations. Retracting such papers is a step in the right direction – insufficient to prevent all sorts of problems associated with endeavours to maintain the quality of the literature, but necessary.
As for the specific case of Arati Ramesh: she defended her group’s paper on PubPeer in two comments that offered more raw data and seemed to be founded on a conviction that the images in the paper were real, not doctored. Some commentators have said that her attitude is a sign that she didn’t know the images had been doctored while some others have said (and I tend to agree) that this defence of Ramesh is baffling considering both of her comments succeeded detailed descriptions of forgery. Members of the latter group have also said that, in effect, Ramesh tried to defend her paper until it was impossible to do so, at which point she published her controversial personal statement in which she threw one of her lab’s students under the bus.
There are a lot of missing pieces here towards ascertaining the scope and depth of Ramesh’s culpability – given also that she is the lab’s principal investigator (PI), that she is the lab’s PI who has since started to claim that her lab doesn’t have access to the experiments’ raw data, and that the now-retracted paper says that she “conceived the experiments, performed the initial bioinformatic search for Sensei RNAs, supervised the work and wrote the manuscript”.
[Edit, July 11, 2021, 6:28 pm: After a conversation with Priyanka Pulla, I edited the following paragraph. The previous version appears below, struck through.]
Against this messy background, are we setting a low bar by giving Arati Ramesh brownie points for retracting the paper? Yes and no… Even if it were the case that someone defended the indefensible to an irrational degree, and at the moment of realisation offered to take the blame while also explicitly blaming someone else, the paper was retracted. This is the ‘no’ part. The ‘yes’ arises from Ramesh’s actions on PubPeer, to ‘keep going until one can go no longer’, so to speak, which suggests, among other things – and I’m shooting in the dark here – that she somehow couldn’t spot the problem right away. So giving her credit for the retraction would set a low, if also weird, bar; I think credit belongs on this count with the fastidious commenters of PubPeer. Ramesh would still have had to sign off on a document saying “we’ve agreed to have the paper retracted”, as journals typically require, but perhaps we can also speculate as to whom we should really thank for this outcome – anyone/anything from Ramesh herself to the looming threat of public pressure.
Against this messy background, are we setting a low bar by giving Arati Ramesh brownie points for retracting the paper? No. Even if it were the case that someone defended the indefensible to an irrational degree, and at the moment of realisation offered to take the blame while also explicitly blaming someone else, the paper was retracted. Perhaps we can speculate as to whom we should thank for this outcome – Arati Ramesh herself, someone else in her lab, members of the internal inquiry committee that NCBS set up, some others members of the institute or even the looming threat of public pressure. We don’t have to give Ramesh credit here beyond her signing off on the decision (as journals typically require) – and we still need answers on all the other pieces of this puzzle, as well as accountability.
A final point: I hope that the intense focus that the NCBS fracas has commanded – and could continue to considering Bik has flagged one more paper coauthored by Ramesh and others have flagged two coauthored by her partner Sunil Laxman (published in 2005 and 2006), both on PubPeer for potential image manipulation – will widen to encompass the many instances of misconduct popping up every week across the country.
NCBS, as we all know, is an elite institute as India’s centres of research go: it is well-funded (by the Department of Atomic Energy, a government body relatively free from bureaucratic intervention), staffed by more-than-competent researchers and students, has published commendable research (I’m told), has a functional outreach office, and whose scientists often feature in press reports commenting on this or that other study. As such, it is overrepresented in the public imagination and easily gets attention. However, the problems assailing NCBS vis-à-vis the reports on PubPeer are not unique to the institute, and should in fact force us to rethink our tendency (mine included) to give such impressive institutes – often, and by no coincidence, Brahmin strongholds – the benefit of the doubt.
(1. I have no idea how things are at India’s poorly funded state and smaller private universities, but even there, and in fact at the overall less-elite and but still “up there” in terms of fortunes, institutes, like the IISERs, Brahmins have been known to dominate the teaching and professorial staff, if not the students, and still have been found guilty of misconduct, often sans accountability. 2. There’s a point to be made here about plagiarism, the graded way in which it is ‘offensive’, access to good quality English education to people of different castes in India, a resulting access to plus inheritance of cultural and social capital, and the funneling of students with such capital into elite institutes.)
As I mentioned earlier, Retraction Watch has an ‘India retractions’ category (although to be fair, there are also similar categories for China, Italy, Japan and the UK, but not for France, Russia, South Korea or the US. These countries ranked 1-10 on the list of countries with the most scientific and technical journal publications in 2018.) Its database lists 1,349 papers with at least one author affiliated with an Indian institute that have been retracted – and five papers since the NCBS one met its fate. The latest one was retracted on July 7, 2021 (after being published on October 16, 2012). Again, these are just instances in which a paper was retracted. Further up the funnel, we have retractions that Retraction Watch missed, papers that editors are deliberating on, complaints that editors have rejected, complaints that editors have ignored, complaints that editors haven’t yet received, and journals that don’t care.
– and retractors – deserve brownie points.